ORASURE TECHNOLOGIES, INC Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
ORASURE TECHNOLOGIES, INC (OSUR) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of -1.10% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-03-09
- ORASURE TECHNOLOGIES, INC effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2025 was -1.10%.
- ORASURE TECHNOLOGIES, INC effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2024 was -2.30%.
- ORASURE TECHNOLOGIES, INC effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2023 was -0.30%.
- ORASURE TECHNOLOGIES, INC effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2022 was -5.10%, a 254.55% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -1.10% 10-K · filed 2026-03-09 | |
| 2024-12-31 | -2.30% 10-K · filed 2025-03-07 | |
| 2023-12-31 | -0.30% 10-K · filed 2025-03-07 | 0.30% 10-K · filed 2024-03-11 |
| 2022-12-31 | -5.10% 10-K · filed 2025-03-07 | -4.80% 10-K · filed 2023-03-03 |
| 2021-12-31 | 3.30% 10-K · filed 2024-03-11 | -3.30% 10-K · filed 2022-03-01 |
| 2020-12-31 | -12.40% 10-K · filed 2023-03-03 | |
| 2019-12-31 | -5.30% 10-K · filed 2022-03-01 | |
| 2018-12-31 | 0.60% 10-K · filed 2021-03-01 | |
| 2017-12-31 | -16.00% 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |